Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Physiol Res ; 70(6): 851-863, 2021 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-34717058

RESUMEN

Metabolic syndrome (MetS) belongs to the serious health complications expanding in cardiovascular diseases, obesity, insulin resistance, and hyperglycemia. In this study, hypertriacylglycerolemic rats fed a high-fat-fructose diet (HFFD) were used as an experimental model of MetS to explore the effect of tested compounds. Effects of a new prospective pyridoindole derivative coded SMe1EC2 and the natural polyphenol rutin were tested. Endothelial nitric oxide synthase (NOS3) and nuclear factor kappa B (NF-?B) expression were assessed in the left ventricle immunohistochemically and left ventricle activity was monitored in isolated perfused rat hearts. NOS3 activity in the left ventricle decreased markedly as a result of a HFFD. NOS3 expression was upregulated by both substances. NF-?B expression was increased in the MetS group in comparison to control rats and the expression further increased in the SMe1EC2 treatment. This compound significantly improved the coronary flow in comparison to the control group during reperfusion of the heart followed after ischemia. Further, it tended to increase left ventricular systolic pressure, heart product, rate of maximal contraction and relaxation, and coronary flow during baseline assessment. Moreover, the compound SMe1EC2 decreased the sensitivity of hearts to electrically induced ventricular fibrillation. Contrary to this rutin decreased coronary flow in reperfusion. Present results suggest that despite upregulation of NOS3 by both substances tested, pyridoindole SMe1EC2 rather than rutin could be suitable in treatment strategies of cardiovascular disorders in MetS-like conditions.


Asunto(s)
Corazón/efectos de los fármacos , Indoles/uso terapéutico , Síndrome Metabólico/tratamiento farmacológico , Óxido Nítrico Sintasa de Tipo III/metabolismo , Piridinas/uso terapéutico , Rutina/uso terapéutico , Animales , Biometría , Evaluación Preclínica de Medicamentos , Fructosa/efectos adversos , Indoles/farmacología , Masculino , Síndrome Metabólico/enzimología , Síndrome Metabólico/etiología , Miocardio/metabolismo , FN-kappa B/metabolismo , Piridinas/farmacología , Ratas Wistar , Rutina/farmacología
2.
Physiol Res ; 65 Suppl 1: S77-90, 2016 09 19.
Artículo en Inglés | MEDLINE | ID: mdl-27643942

RESUMEN

Thyroid hormones are powerful modulators of heart function and susceptibility to arrhythmias via both genomic and non-genomic actions. We aimed to explore expression of electrical coupling protein connexin-43 (Cx43) in the heart of rats with altered thyroid status and impact of omega-3 polyunsaturated fatty acids (omega-3) supplementation. Adult male Lewis rats were divided into following six groups: euthyroid controls, hyperthyroid (treated with T(3)) and hypothyroid (treated with methimazol) with or without six-weeks lasting supplementation with omega-3 (20 mg/100 g/day). Left and right ventricles, septum and atria were used for immunoblotting of Cx43 and protein kinase C (PKC). Total expression of Cx43 and its phosphorylated forms were significantly increased in all heart regions of hypothyroid rats compared to euthyroid controls. In contrast, the total levels of Cx43 and its functional phosphorylated forms were decreased in atria and left ventricle of hyperthyroid rats. In parallel, the expression of PKC epsilon that phosphorylates Cx43, at serine 368, was increased in hypothyroid but decreased in hyperthyroid rat hearts. Omega-3 intake did not significantly affect either Cx43 or PKC epsilon alterations. In conclusion, there is an inverse relationship between expression of cardiac Cx43 and the levels of circulating thyroid hormones. It appears that increased propensity of hyperthyroid while decreased of hypothyroid individuals to malignant arrhythmias may be in part attributed to the changes in myocardial Cx43.


Asunto(s)
Conexina 43/metabolismo , Ácidos Grasos Omega-3/farmacología , Corazón/efectos de los fármacos , Hipertiroidismo/metabolismo , Hipotiroidismo/metabolismo , Proteína Quinasa C/metabolismo , Animales , Suplementos Dietéticos , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Miocardio/enzimología , Fosforilación , Distribución Aleatoria , Ratas Endogámicas Lew , Hormonas Tiroideas/sangre
3.
Phytother Res ; 27(7): 1018-22, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22933407

RESUMEN

In the present study, we investigated the potential protective effect of selected natural substances in a rat model of heart and mesenteric ischemia-reperfusion (I/R). Experiments were performed on isolated Langendorff-perfused rat hearts, subjected to 30-min global ischemia, followed by 30-min reperfusion. Arbutin, curcumin, rosmarinic acid and extract of Mentha x villosa were applied in the concentration of 1 × 10⁻5 mol/l 10 min before the onset of ischemia and during reperfusion, through the perfusion medium. Mesenteric ischemia was induced by clamping the superior mesenteric artery (SMA) for 60 min, subsequent reperfusion lasted 30 min. Production of reactive oxygen species (ROS) by SMA ex vivo was determined by luminol-enhanced chemiluminiscence (CL). The effect of the substances was tested after their incubation with tissue. Curcumin and extract of Mentha x villosa were found to be the most effective in reducing reperfusion-induced dysrhythmias--ventricular tachycardia and fibrillation. This effect was accompanied by bradycardic effect. The mesenteric I/R induced an increase in CL in vascular tissue which was dampened by substances tested. All substances tested were found to have antioxidant properties, as demonstrated by a reduction in ROS production in mesenteric vessels. This effect was confirmed in curcumin and extract of Mentha x villosa which reduced reperfusion dyshythmias.


Asunto(s)
Preparaciones de Plantas/uso terapéutico , Polifenoles/uso terapéutico , Daño por Reperfusión/tratamiento farmacológico , Animales , Antioxidantes/uso terapéutico , Arbutina/uso terapéutico , Cinamatos/uso terapéutico , Curcumina/uso terapéutico , Depsidos/uso terapéutico , Masculino , Mentha/química , Arteria Mesentérica Superior/efectos de los fármacos , Arteria Mesentérica Superior/fisiopatología , Daño por Reperfusión Miocárdica/tratamiento farmacológico , Fitoterapia , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno , Daño por Reperfusión/fisiopatología , Taquicardia Ventricular/tratamiento farmacológico , Fibrilación Ventricular/tratamiento farmacológico , Ácido Rosmarínico
4.
J Physiol Pharmacol ; 61(6): 717-23, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21224503

RESUMEN

Omega-3 fatty acids (omega-3 FA) and statins exhibit besides lipid-lowering effects the antiarrhythmic ability in clinic, while definite mechanisms are not yet elucidated. Our goal was to examine whether these compounds can modulate inducibility of hypertriglyceridemic (HTG) rat heart to ventricular fibrillation (VF) and myocardial cell-to-cell coupling protein connexin-43 (Cx43). HTG and healthy Wistar rats were orally treated with omega-3 FA(30 mg/100 g/day/2 mth) and atorvastatin (Ato, 0.5 mg/100 g/day/2 mth) and compared to untreated rats. Susceptibility of the heart to electrically-inducible VF and functional parameters were monitored using Langendorff-perfused isolated heart. Ventricular tissues from treated and untreated HTG and Wistar rat hearts were processed for ultrastructure examination as well as for analysis of myocardial Cx43 distribution and expression using antiCx43 MAB, immunofluorescence and immunoblotting. Both, omega-3 FA and atorvastatin reduced elevated blood pressure, triglycerides and heart rate in HTG rats. Compared to Wistar the threshold to induce VF was lower in HTG rat hearts, which exhibited abnormal Cx43 distribution, decreased immunostaining and elevated phosphorylated form of Cx43. In contrast, an enhancement of immunostaining of Cx43, suppression of hyperphosphorylation of Cx43 and improvement of cardiomyocyte and intercellular junction integrity by omega-3 FA and atorvastatin was associated with a significant increase of threshold for VF. Moreover, treatment resulted in up-regulation of myocardial Cx43 and increase of VF threshold in healthy rats that was associated with up-regulation of Cx43. Results indicate that antiarrhythmic effects of omega-3 FA and atorvastatin are linked with modulation of expression and/or phosphorylation of Cx43 and protection of cardiomyocyte and cell-to-cell junction integrity. As both compounds are ligands for PPAR, a possible regulation of Cx43 gene expression and pathways involved in Cx43 phosphorylation should be investigated.


Asunto(s)
Conexina 43/metabolismo , Ácidos Grasos Omega-3/farmacología , Ácidos Heptanoicos/farmacología , Hipertrigliceridemia/tratamiento farmacológico , Pirroles/farmacología , Fibrilación Ventricular/metabolismo , Animales , Arritmias Cardíacas/genética , Arritmias Cardíacas/metabolismo , Atorvastatina , Presión Sanguínea/efectos de los fármacos , Conexina 43/genética , Frecuencia Cardíaca/efectos de los fármacos , Ventrículos Cardíacos/metabolismo , Hipertrigliceridemia/metabolismo , Miocardio/metabolismo , Miocitos Cardíacos/efectos de los fármacos , Fosforilación/efectos de los fármacos , Ratas , Ratas Wistar , Triglicéridos/metabolismo , Regulación hacia Arriba/efectos de los fármacos
5.
Physiol Res ; 57 Suppl 2: S39-S48, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18373394

RESUMEN

Hypertension-induced myocardial metabolic, structural and electrophysiological remodeling deteriorates with aging and contributes to both heart failure and occurrence of malignant arrhythmias. It has been shown in clinical trials that n-3 polyunsaturated fatty acids (n-3 PUFA) reduce the incidence of cardiovascular diseases and sudden cardiac death. We investigated the cardioprotective effects of n-3 PUFA in aged spontaneously hypertensive rats (SHR) and possible cellular mechanisms involved. Male and female 14-moth-old SHR were fed with n-3 PUFA (Vesteralens, Norway, 20 mg/day for two months) and compared with untreated SHR. Results showed that n-3 PUFA supplementation led to 1) significant decline of blood pressure; 2) suppression of inducible ventricular fibrillation (VF) by 57 % (male) and 67 % (female), although the arrhythmogenic substrates, like fibrosis, hypertrophy and abnormal gap junctions distribution were not eliminated; 3) preservation of the cardiomyocytes and the integrity of their junctions; 4) enhancement of energetic metabolism enzyme activity; 5) augmentation of capillary density associated with increased alkaline phosphatase and decreased dipeptidyl peptidase-4 (DPP4) activity and 6/ increase in gap junction channel connexin-43 expression. Thus, aged male as well as female SHR benefit from n-3 PUFA supplementation that results in decrease in VF susceptibility, partly due to an improvement of myocardial metabolic state, cardiomyocyte and cell-to-cell junctions integrity and Cx43 up-regulation.


Asunto(s)
Suplementos Dietéticos , Ácidos Grasos Omega-3/farmacología , Hipertensión/tratamiento farmacológico , Miocardio/metabolismo , Fibrilación Ventricular/prevención & control , Factores de Edad , Animales , Presión Sanguínea/efectos de los fármacos , Capilares/efectos de los fármacos , Conexina 43/metabolismo , Modelos Animales de Enfermedad , Metabolismo Energético/efectos de los fármacos , Femenino , Hipertensión/complicaciones , Hipertensión/metabolismo , Hipertensión/fisiopatología , Masculino , Miocardio/enzimología , Miocardio/patología , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Ratas , Ratas Endogámicas SHR , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo , Fibrilación Ventricular/etiología , Fibrilación Ventricular/metabolismo , Fibrilación Ventricular/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA